|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | K65(X80)管线钢断口分离及其对冲击韧性的影响显示文摘为了研究K65(X80)钢断口分离对冲击韧性的影响,对不同生产厂家的4种典型K65(X80)高韧性管线钢进行了+20^-90℃夏比冲击试验,并对冲击试样断口分离形貌和尺寸进行了分析。结果表明,均匀韧性断口的高能量区长度Lh与冲击韧性A_(kV)直接相关,考虑了试验温度下降时断口分离形式和数量的变化,确定了管线钢获得高冲击韧性(-60℃A_(kV)≥250 J/cm^2)的条件。 | 方伟(编译) 邹斌(编译) 李为卫(编译) 吕华(编译) FARBER V M KHOTINOV V A MOROZOVA A N | 2018 | 焊管2018，41，2： | 5 |
| 2 | Current evidence on potential of adipose derived stem cells to enhance bone regeneration and future projection显示文摘Injuries to the postnatal skeleton are naturally repaired through successive stepsinvolving specific cell types in a process collectively termed “bone regeneration”.Although complex, bone regeneration occurs through a series of well-orchestratedstages wherein endogenous bone stem cells play a central role. In most situations,bone regeneration is successful;however, there are instances when it fails andcreates non-healing injuries or fracture nonunion requiring surgical or therapeuticinterventions. Transplantation of adult or mesenchymal stem cells (MSCs) definedby the International Society for Cell and Gene Therapy (ISCT) as CD105+-CD90+CD73+CD45-CD34-CD14orCD11b-CD79αorCD19-HLA-DR- is beinginvestigated as an attractive therapy for bone regeneration throughout the world.MSCs isolated from adipose tissue, adipose-derived stem cells (ADSCs), aregaining increasing attention since this is the most abundant source of adult stemcells and the isolation process for ADSCs is straightforward. Currently, there isnot a single Food and Drug Administration (FDA) approved ADSCs product forbone regeneration. Although the safety of ADSCs is established from their usagein numerous clinical trials, the bone-forming potential of ADSCs and MSCs, ingeneral, is highly controversial. Growing evidence suggests that the ISCT definedphenotype may not represent bona fide osteoprogenitors. Transplantation of bothADSCs and the CD105- sub-population of ADSCs has been reported to induce bone regeneration. Most notably, cells expressing other markers such as CD146,AlphaV, CD200, PDPN, CD164, CXCR4, and PDGFRα have been shown torepresent osteogenic sub-population within ADSCs. Amongst other strategies toimprove the bone-forming ability of ADSCs, modulation of VEGF, TGF-β1 andBMP signaling pathways of ADSCs has shown promising results. The U.S. FDAreveals that 73% of Investigational New Drug applications for stem cell-basedproducts rely on CD105 expression as the “positive” marker for adult stem cells.A concerted effort involving the scientific community, clinicians, industries, andregulatory bodies to redefine ADSCs using powerful selection markers andstrategies to modulate signaling pathways of ADSCs will speed up thetherapeutic use of ADSCs for bone regeneration. | Quang Le Vedavathi Madhu Joseph M Hart Charles R Farber Eli R Zunder Abhijit S Dighe Quanjun Cui | 2021 | World Journal of Stem Cells2021，13，9： | 2 |
| 3 | Inactivation of hepatitis A virus (HAV) in fruits and vegetables by gamma irradiation显示文摘 | BIDAWID S FARBER J M SATTAR S A | 2000 | Int J Food Microbiol2000，57，12： | 1 |
| 4 | Coverage of the left subclavian artery during thoracic endovascular aortic repair 显示文摘 | Riesenman P J Farber M A Mendes R R | 2007 | J Vasc Surg2007，45，1： | 1 |
| 5 | Cha- racterizing the antigenic profile of the human trachea: implica- tions for tracheal transplantation显示文摘 | SHAARI C M FARBER D BRANDWEIN M S | 1998 | Head Neck1998，20，6： | 1 |
| 6 | Phenotypic and genotypic typing of food and clinical isolates of Enterobacter sakazakii 显示文摘 | NAZAROWEC-WHITE M FARBER J M | 1999 | J Med Microbiol1999，48，6： | 1 |
| 7 | Listeria monocytogenes, a food-bome pathogen 显示文摘 | Farber J M Peterkin P I | 1991 | J Microbiological reviews1991，55，3： | 1 |
| 8 | Recoverability of Communication Protocols Implications of a Theoretical Study 显示文摘 | MERLIN P M FARBER D J | 1976 | IEEE Trans on Communications1976，24，9： | 1 |
| 9 | Enterobacter sakazakii-new foods from thought显示文摘 | FARBER J M | 2004 | Lancet2004，363，9402： | 1 |
| 10 | Listeria monocytogenes a foodbome pathogen显示文摘 | FARBER J M PETERKIN P I | 1991 | Microbiol Rev1991，9，： | 1 |
| 11 | Reducing costs and pa- tient morbidity in the enterally fed intensive care unit pa- tient显示文摘 | Farber M S Moses J Korn M | 2005 | JPEN J Parenter Enteral Nutr2005，29，1： | 1 |
| 12 | Enterobacter sakazakii:a review显示文摘 | Nazarowec-White M Farber JM | 1997 | Int J Food Microbiol1997，34，2： | 1 |
| 13 | Pharmacokinetics of therapeutic doses of tropisetron in healthy volunteers显示文摘 | Kees F Farber L Bucher M | 2001 | Br J Clin Pharmacol2001，52，6： | 1 |
| 14 | Incidence, survival, and growth of Enterobacter sakazakii in infant formula显示文摘 | Nazarowec- White M JM Farber | 1997 | J Food Prot1997，60，： | 1 |
| 15 | Presentation of antigenic sites from foot-and-mouth disease virus on the surface of baculovirus and in the membrane of infected cells显示文摘 | Tami C Farber M Palma E L | 2000 | Arch Virol2000，145，9： | 1 |
| 16 | High-resolution transmission electron microscopy of Ti4AlN3 or Ti3Al2N2 revisited 显示文摘 | BARSOUM M W FARBER L LEVIN I PROCOPIO A E1-RAGHY T BERNER A | 1999 | Journal of the American Ceramic Society1999，82，9： | 1 |
| 17 | Presentation of an tigenic sites from foot and mouth disease virus on the surface of baculovirus and in the membrane of infected cells 显示文摘 | Tami C Farber M Palma E L | 2000 | Arch Virol2000，145，9： | 1 |
| 18 | Reducing costs and patient morbidity in the enterally fed intensive care unit patient显示文摘 | Farber MS Moses J Kom M | 2005 | JPEN2005，29，1： | 1 |
| 19 | Enterobacter sakazakii: a review 显示文摘 | Nazarowec-White M Farber J M | 1997 | Int J Food Microbiol1997，34，2： | 1 |
| 20 | An alpha5betal integrin inhibitor attenuates glioma growth 显示文摘 | Farber K Synowitz M Zahn G | 2008 | Mol Cell Neurosci2008，39，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员